Rodríguez-López JN - Search Results

1

Targeting the epigenetics of the DNA damage response in breast cancer.

Montenegro MF, González-Guerrero R, Sánchez-del-Campo L, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Montenegro MF, et al. Cell Death Dis. 2016 Apr 7;7(4):e2180. doi: 10.1038/cddis.2016.85. Cell Death Dis. 2016. PMID: 27054335 Free PMC article.

2

Targeting the epigenetic machinery of cancer cells.

Montenegro MF, Sánchez-del-Campo L, Fernández-Pérez MP, Sáez-Ayala M, Cabezas-Herrera J, Rodríguez-López JN. Montenegro MF, et al. Oncogene. 2015 Jan 8;34(2):135-43. doi: 10.1038/onc.2013.605. Epub 2014 Jan 27. Oncogene. 2015. PMID: 24469033 Review.

3

Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis.

Montenegro MF, Sánchez-Del-Campo L, González-Guerrero R, Martínez-Barba E, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Montenegro MF, et al. Oncogene. 2016 Nov 24;35(47):6143-6152. doi: 10.1038/onc.2016.154. Epub 2016 May 2. Oncogene. 2016. PMID: 27132511

4

The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression.

Navarro-Perán E, Cabezas-Herrera J, Sánchez-Del-Campo L, García-Cánovas F, Rodríguez-López JN. Navarro-Perán E, et al. Inflamm Res. 2008 Oct;57(10):472-8. doi: 10.1007/s00011-008-8013-x. Inflamm Res. 2008. PMID: 18830563

5

Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.

Piñero-Madrona A, Ruiz-Merino G, Cerezuela Fuentes P, Martínez-Barba E, Rodríguez-López JN, Cabezas-Herrera J. Piñero-Madrona A, et al. Clin Transl Oncol. 2019 Oct;21(10):1348-1356. doi: 10.1007/s12094-019-02064-4. Epub 2019 Feb 19. Clin Transl Oncol. 2019. PMID: 30783917

6

Inhibition of Stenotrophomonas maltophilia dihydrofolate reductase by methotrexate: a single slow-binding process.

Navarro-Martínez MD, Cabezas-Herrera J, García-Cánovas F, Rodríguez-López JN. Navarro-Martínez MD, et al. J Enzyme Inhib Med Chem. 2007 Aug;22(4):377-82. doi: 10.1080/14756360601141653. J Enzyme Inhib Med Chem. 2007. PMID: 17847703 Free article.

7

Effect of tetrahydropteridines on the monophenolase and diphenolase activities of tyrosinase.

García Molina F, Muñoz JL, Varón R, Rodríguez López JN, García Cánovas F, Tudela J. García Molina F, et al. J Enzyme Inhib Med Chem. 2007 Aug;22(4):383-94. doi: 10.1080/14756360701189776. J Enzyme Inhib Med Chem. 2007. PMID: 17847704 Free article.

8

Melanogenesis inhibition by tetrahydropterines.

García-Molina F, Munoz-Munoz JL, Acosta JR, García-Ruiz PA, Tudela J, García-Cánovas F, Rodríguez-López JN. García-Molina F, et al. Biochim Biophys Acta. 2009 Dec;1794(12):1766-74. doi: 10.1016/j.bbapap.2009.08.011. Epub 2009 Aug 18. Biochim Biophys Acta. 2009. PMID: 19695351

9

Mushroom tyrosinase has an ascorbate oxidase activity.

Ros JR, Rodríguez-López JN, Varón-Castellanos R, García-Canovas F. Ros JR, et al. Biochem Mol Biol Int. 1995 Jun;36(2):301-9. Biochem Mol Biol Int. 1995. PMID: 7663434

10

Tyrosinase: kinetic analysis of the transient phase and the steady state.

Ros JR, Rodríguez-López JN, García-Cánovas F. Ros JR, et al. Biochim Biophys Acta. 1994 Jan 11;1204(1):33-42. doi: 10.1016/0167-4838(94)90029-9. Biochim Biophys Acta. 1994. PMID: 8305473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters